ATHIRA PHARMA INC's ticker is ATHA and the CUSIP is 04746L104. A total of 71 filers reported holding ATHIRA PHARMA INC in Q3 2023. The put-call ratio across all filers is 0.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,430,875 | -31.5% | 1,698,453 | 0.0% | 0.00% | – |
| Q2 2023 | $5,010,436 | +8.8% | 1,698,453 | -7.8% | 0.00% | – |
| Q1 2023 | $4,606,613 | -20.9% | 1,842,645 | +0.3% | 0.00% | – |
| Q4 2022 | $5,826,248 | +7.1% | 1,837,933 | +0.3% | 0.00% | – |
| Q3 2022 | $5,441,000 | +10.8% | 1,832,030 | +13.7% | 0.00% | – |
| Q2 2022 | $4,912,000 | -75.9% | 1,610,580 | +6.6% | 0.00% | – |
| Q1 2022 | $20,400,000 | +2.0% | 1,511,078 | -1.6% | 0.00% | – |
| Q4 2021 | $20,005,000 | +29.9% | 1,535,241 | -6.5% | 0.00% | – |
| Q3 2021 | $15,397,000 | +9.9% | 1,641,483 | +20.0% | 0.00% | – |
| Q2 2021 | $14,004,000 | -2.4% | 1,367,599 | +75.5% | 0.00% | – |
| Q1 2021 | $14,342,000 | -35.2% | 779,468 | +20.6% | 0.00% | -100.0% |
| Q4 2020 | $22,131,000 | +1098.2% | 646,165 | +546.2% | 0.00% | – |
| Q3 2020 | $1,847,000 | – | 100,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 1,691,623 | $57,938,000 | 8.52% |
| ACUTA CAPITAL PARTNERS, LLC | 393,000 | $13,460,000 | 3.66% |
| Logos Global Management LP | 947,873 | $32,465,000 | 2.78% |
| RTW INVESTMENTS, LP | 2,685,779 | $88,899,000 | 1.49% |
| Avidity Partners Management LP | 1,043,873 | $35,753,000 | 1.16% |
| Perceptive Advisors | 3,114,805 | $106,682,000 | 1.14% |
| Sofinnova Investments, Inc. | 509,168 | $17,439,000 | 1.04% |
| HighVista Strategies LLC | 32,062 | $1,098,000 | 0.70% |
| Rock Springs Capital Management LP | 860,902 | $29,486,000 | 0.62% |
| PFM Health Sciences, LP | 470,227 | $16,105,000 | 0.57% |